Quantitative Imaging Reveals Steatosis and Fibroinflammation in Multiple Organs in People With Type 2 Diabetes: A Real-World Study
Diabetes · 01.08.2024 · 73 (8) · 1285-1299
DOI: 10.2337/db23-0926 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, online erschienen am 14.05.2024. Verfasst von Charlie Diamond und 9 weiteren Autor:innen. Beteiligte Einrichtung: Perspectum, Ltd., Oxford, U.K. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Magnetic Resonance Imaging, Inflammation. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Innovate UK, UK Biobank.
Themen: Diabetes mellitus
Abstract (Originalsprache)
We aimed to determine the extent of multiorgan fat accumulation and fibroinflammation in individuals living with type 2 diabetes. We deeply phenotyped individuals with type 2 diabetes (134 from secondary care, 69 from primary care) with multiorgan, quantitative, multiparametric MRI and compared with 134 matched control individuals without diabetes and 92 control individuals with normal weight. We examined the impact of diabetes duration, obesity status, and glycemic control. Ninety-three of the individuals with type 2 diabetes were reevaluated at 7 months (median). Multiorgan abnormalities were more common in individuals with type 2 diabetes (94%) than in age- and BMI-matched healthy individuals or healthy individuals with normal weight. We demonstrated a high burden of combined steatosis and fibroinflammation within the liver, pancreas, and kidneys (41%, 17%, and 10%) associated with visceral adiposity (73%) and poor vascular health (82%). Obesity was most closely associated with advanced liver disease, renal and visceral steatosis, and multiorgan abnormalities, while poor glycemic control was associated with pancreatic fibroinflammation. Pharmacological therapies with proven cardiorenal protection improved liver and vascular health unlike conventional glucose-lowering treatments, while weight loss or improved glycemic control reduced multiorgan adiposity (P ≤ 0.01). Quantitative imaging in people with type 2 diabetes highlights widespread organ abnormalities and may provide useful risk and treatment stratification. Article Highlights
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Perspectum, Ltd., Oxford, U.K.
- Clinica Di Radiologia EOC, Istituto Di Imaging Della Svizzera Italiana, Ente Ospedaliero Cantonale, Lugano, Switzerland.
- Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, U.K.
- Wellcome Centre for Integrative Neuroimaging, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, U.K.
- Perspectum, Inc., Dallas, TX.
- Royal Free London NHS Foundation Trust, London, U.K.
ORCID-Profile: Helena Thomaides Brears
Förderung
- Innovate UK
- UK Biobank
Zitieren
APA
Diamond, C., Pansini, M., Hamid, A., Eichert, N., Pandya, P., Ali, S. N., Kemp, G. J., Thanabalasingham, G., Thomaides Brears, H., & Cuthbertson, D. J. (2024). Quantitative Imaging Reveals Steatosis and Fibroinflammation in Multiple Organs in People With Type 2 Diabetes: A Real-World Study. Diabetes, 73(8), 1285-1299. https://doi.org/10.2337/db23-0926
Vancouver
Diamond C, Pansini M, Hamid A, Eichert N, Pandya P, Ali SN, et al. Quantitative Imaging Reveals Steatosis and Fibroinflammation in Multiple Organs in People With Type 2 Diabetes: A Real-World Study. Diabetes. 2024;73(8):1285-1299. doi:10.2337/db23-0926
BibTeX
@article{Diamond2024,
author = {Diamond, Charlie and Pansini, Michele and Hamid, Azlinda and Eichert, Nicole and Pandya, Prashant and Ali, Sarah N and Kemp, Graham J and Thanabalasingham, Gaya and Thomaides Brears, Helena and Cuthbertson, Daniel J},
title = {Quantitative Imaging Reveals Steatosis and Fibroinflammation in Multiple Organs in People With Type 2 Diabetes: A Real-World Study},
journal = {Diabetes},
year = {2024},
volume = {73},
number = {8},
pages = {1285--1299},
doi = {10.2337/db23-0926}
}
EUVIMED